Solasia Pharma KK (TSE:4597) Marketable Securities: 円0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4597 Solasia Pharma KK TSE:4597
66 GF Score
Price 円28.00
GF Value 円28.20
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Solasia Pharma KK Marketable Securities?

Solasia Pharma KK TSE:4597 66 Marketable Securities is 円0.0 Mil as of Mar. 2026. GuruFocus rates TSE:4597 with a GF Score™ of 66/100 and a GF Value™ of 円28.20 (Fairly Valued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Solasia Pharma KK's Marketable Securities for the quarter that ended in Mar. 2026 was 円0.0 Mil.

Solasia Pharma KK  (TSE:4597) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Solasia Pharma KK Marketable Securities Related Terms

Solasia Pharma KK Marketable Securities Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK Marketable Securities Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Solasia Pharma KK Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4597
66GF Score
Solasia Pharma KK TSE:4597
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円0.0 Mil mean?
Solasia Pharma KK (TSE:4597) has a Marketable Securities of 円0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Marketable Securities too high?
Solasia Pharma KK's current Marketable Securities is 円0.0 Mil. Overall, Solasia Pharma KK has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Marketable Securities compare to ZTS?
Solasia Pharma KK's Marketable Securities of 円0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Solasia Pharma KK and its competitors. Solasia Pharma KK's current Marketable Securities is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Fairly Valued. The stock's GF Value™ is 円28.20, compared to a current price of 円28.00 — trading 0.7% below its estimated fair value. The current Marketable Securities is 円0.0 Mil. Solasia Pharma KK's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Marketable Securities is 円0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be undervalued. The current stock price of 円28.00 is trading 0.7% below its estimated GF Value™ of 円28.20. GuruFocus considers Solasia Pharma KK to be Fairly Valued.

Key valuation signals for TSE:4597:

  • Marketable Securities: 円0.0 Mil
  • GF Value™: 円28.20 vs. price of 円28.00 (0.7% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasia Pharma KK Business Description

Other Exchanges 9SO:Germany
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
66GF Score

Get the complete analysis for TSE:4597

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円28.00
Price
円28.20
GF Value